Biogen (BIIB) Tops Q3 EPS by 31c; raises guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.03 +6.97%
Revenue Growth %: -6.5%
Financial Fact:
Net income: 1.03B
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -6.5%
Financial Fact:
Net income: 1.03B
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $4.08, $0.31 better than the analyst estimate of $3.77. Revenue for the quarter came in at $2.47 billion versus the consensus estimate of $2.43 billion.
GUIDANCE:
Biogen sees FY2024 EPS of $16.10-$16.60, versus the consensus of $16.19.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- Tractor Supply and Starlink team up to expand rural broadband via 4-H
- UBS Downgrades Grand Korea Leisure (114090:KS) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
